Grufity logoGrufity logo

MASS

10.71USD+0.61(+6.04%)Market Closed

908 Devices Inc.

Market Summary

USD10.71+0.61Market Closed
6.04%

MASS Alerts

MASS Stock Price

RSI Chart

Valuation

Market Cap

509.2M

Price/Earnings

-19.45

Price/Sales

10.65

Price/Cashflow

-22.12

Price/Sales

Profitability

Operating Margin

55.88%

Return on Equity

-13.02%

Return on Assets

-10.6%

Fundamentals

Revenue

Revenue (TTM)

51.0M

Revenue Y/Y

25.92%

Revenue Q/Q

42.24%

Earnings

Earnings (TTM)

-27.3M

Earnings Y/Y

-20.71%

Earnings Q/Q

22.72%

Price Action

52 Week Range

28.45
(Low)(High)

Last 7 days

8.2%

Last 30 days

-37.5%

Last 90 days

-47.8%

Trailing 12 Months

-54.2%

Financial Health

Current Ratio

15.46

Investor Care

Shares Dilution (1Y)

13.66%

Diluted EPS (TTM)

-0.87

Financials for 908 Devices

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue6.8%5148454232
Gross Profit9.5%2927242317
Operating Expenses8.2%5853504539
  S&GA Expenses8.0%4138363228
  R&D Expenses8.9%1715141312
Net Income-4.1%-27.25-26.18-25.50-22.20-28.92
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets0.9%249247251261166
  Current Assets-6.2%224239243253157
    Cash Equivalents-9.1%194213223224139
  Inventory4.9%12111088
  Net PPE14.1%32222
Liabilities15.0%5346444644
  Current Liabilities23.6%1915141513
    LT Debt, Non Current0%1515151515
Shareholder's Equity-2.3%197201207215123
  Retained Earnings-5.3%-124.40-118.15-110.05-100.64-97.17
  Additional Paid-In Capital0.7%321319317315220
Shares Outstanding0.4%3232313128
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Thousands)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-8.7%-25,034.00-23,020.00-19,915.00-29,082.00-17,530.00
  Share Based Compensation24.8%6,0764,8673,4542,5041,938
Cashflow From Investing-1803.7%-15,249.00-801.00-1,345.00-737.00-683.00
Cashflow From Financing-0.3%95,30095,61295,42194,725137,376

Risks

What is the probability of a big loss on MASS?

97.1%


Probability that 908 Devices stock will be more than 20% underwater in next one year

89.2%


Probability that 908 Devices stock will be more than 30% underwater in next one year.

89.2%


Probability that 908 Devices stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MASS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if 908 Devices was unfortunately bought at previous high price.

Returns

Cumulative Returns on MASS

Which funds bought or sold MASS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
-122,000
409,000
-%
2022-11-15
STATE STREET CORP
ADDED
7.36
-1,748,000
10,533,000
-%
2022-11-15
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
SOLD OFF
-
-
-
-%
2022-11-15
FRED ALGER MANAGEMENT, LLC
ADDED
223.2
34,865,000
56,902,000
0.29%
2022-11-15
BNP PARIBAS ARBITRAGE, SNC
NEW
-
230,580
230,580
-%
2022-11-15
JANE STREET GROUP, LLC
SOLD OFF
-100
-378,000
-
-%
2022-11-15
ALLIANCEBERNSTEIN L.P.
NEW
-
245,000
245,000
-%
2022-11-14
DEUTSCHE BANK AG\
REDUCED
-13.78
-67,000
150,000
-%
2022-11-14
NORTHERN TRUST CORP
ADDED
2.33
-704,000
3,155,000
-%
2022-11-14
Opaleye Management Inc.
SOLD OFF
-100
-3,426,000
-
-%

1–10 of 46

Latest Funds Activity

Are funds buying MASS calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own MASS

908 Devices News

Benzinga

Our Exclusive Articles.4 days ago

The Motley Fool

MASS Fair Value

Recent SEC filings of 908 Devices

View All Filings
Date Filed Form Type Document
Nov 23, 2022
4
Insider Trading
Nov 22, 2022
4
Insider Trading
Nov 17, 2022
4
Insider Trading
Nov 14, 2022
10-Q
Quarterly Report
Nov 14, 2022
8-K
Current Report
Nov 08, 2022
8-K
Current Report
Oct 19, 2022
4
Insider Trading
Oct 11, 2022
SC 13G
Major Ownership Report
Sep 19, 2022
4
Insider Trading
Sep 14, 2022
4
Insider Trading

Latest Insider Trading transactions for MASS

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-22
Spoto Mark
BOUGHT
24,945.2
9.65
2,585
-
2022-11-21
HRUSOVSKY E KEVIN
ACQUIRED
26,605.6
0.35
76,016
-
2022-11-15
Knopp Kevin J.
SOLD
-220,759
11.038
-20,000
President and CEO
2022-10-18
Knopp Kevin J.
SOLD
-288,016
15.32
-18,800
President and CEO
2022-10-17
Knopp Kevin J.
SOLD
-164,416
14.68
-11,200
President and CEO
2022-09-15
Knopp Kevin J.
SOLD
-508,200
16.94
-30,000
President and CEO
2022-09-12
Brown Christopher D.
SOLD
-391,600
19.58
-20,000
Chief Technology Officer
2022-08-17
Turner Michael S.
ACQUIRED
39,550
7.91
5,000
VP, General Counsel
2022-08-17
Turner Michael S.
SOLD
-90,750
18.15
-5,000
VP, General Counsel
2022-08-15
Knopp Kevin J.
SOLD
-578,063
19.2688
-30,000
President and CEO

1–10 of 50

Kevin J. Knopp
60
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

MASS Income Statement

2022-09-30
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue$ 15,797$ 12,545$ 35,209$ 26,365
Cost of revenue6,4595,73315,10812,266
Gross profit9,3386,81220,10114,099
Operating expenses:    
Research and development4,6663,30212,8649,322
Selling, general and administrative11,8268,78632,28123,318
Total operating expenses16,49212,08845,14532,640
Loss from operations(7,154)(5,276)(25,044)(18,541)
Other income (expense):    
Interest expense(33)(31)(68)(446)
Other income, net9281221,340283
Total other income (expense), net895911,272(163)
Net loss$ (6,259)$ (5,185)$ (23,772)$ (18,704)
Net loss per share, basic$ (0.20)$ (0.19)$ (0.76)$ (0.68)
Net loss per share, diluted$ (0.20)$ (0.19)$ (0.76)$ (0.68)
Weighted average common shares outstanding, basic31,606,48427,707,85831,441,61127,446,149
Weighted average common shares outstanding, diluted31,606,48427,707,85831,441,61127,446,149
Product and service revenue    
Revenue$ 15,437$ 12,285$ 34,074$ 25,557
Cost of revenue6,3665,65614,76812,062
License and contract revenue    
Revenue3602601,135808
Cost of revenue$ 93$ 77$ 340$ 204

MASS Balance Sheet

2022-09-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 193,698$ 224,073
Accounts receivable, net of allowance for doubtful accounts of $1,75015,23116,375
Inventory11,7317,918
Prepaid expenses and other current assets3,2224,527
Total current assets223,882252,893
Operating lease, right-of-use assets4,2715,182
Property and equipment, net2,7611,603
Goodwill9,200 
Intangible assets, net7,969 
Other long-term assets1,1981,228
Total assets249,281260,906
Current liabilities:  
Accounts payable1,6631,371
Accrued expenses8,5646,961
Deferred revenue7,4195,160
Operating lease liabilities1,4321,344
Total current liabilities19,07814,836
Long-term debt15,00015,000
Operating lease liabilities, net of current portion3,4294,508
Deferred revenue, net of current portion12,16211,958
Deferred income taxes2,570 
Other long-term liabilities542 
Total liabilities52,78146,302
Commitments and contingencies (Note 10)
Stockholders' equity:  
Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued or outstanding at September 30, 2022 and December 31, 2021, respectively
Common stock, $0.001 par value; 100,000,000 shares authorized; 31,652,058 shares and 31,077,004 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively3231
Additional paid-in capital321,491315,210
Accumulated other comprehensive loss(613) 
Accumulated deficit(124,410)(100,637)
Total stockholders' equity196,500214,604
Total liabilities and stockholders' equity$ 249,281$ 260,906